Veradigm Inc. (MDRX) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Veradigm Inc. (MDRX) has a cash flow conversion efficiency ratio of 0.024x as of September 2022. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($28.14 Million) by net assets ($1.18 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Veradigm Inc. - Cash Flow Conversion Efficiency Trend (1998–2024)
This chart illustrates how Veradigm Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Read MDRX total liabilities for a breakdown of total debt and financial obligations.
Veradigm Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Veradigm Inc. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Yanpai Filtration Technology Co.Ltd.
SHE:301081
|
N/A |
|
Anhui Ronds Science & Technology Inc Co
SHG:688768
|
-0.654x |
|
Yaari Digital Integrated Services Limited
NSE:YAARI
|
0.000x |
|
Hunan Mendale Hometextile Co Ltd
SHE:002397
|
0.041x |
|
Martinrea International Inc.
TO:MRE
|
0.070x |
|
SECHE ENVIRO.UNSP.ADR 1/5
F:SCB0
|
N/A |
|
Monro Muffler Brake Inc
NASDAQ:MNRO
|
0.029x |
|
Beijing Emerging Eastern Aviation Equipment Co Ltd Class A
SHE:002933
|
0.010x |
Annual Cash Flow Conversion Efficiency for Veradigm Inc. (1998–2024)
The table below shows the annual cash flow conversion efficiency of Veradigm Inc. from 1998 to 2024. For the full company profile with market capitalisation and key ratios, see MDRX company net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $1.02 Billion | $115.56 Million | 0.114x | 0.00% |
| 2022-12-31 | $1.02 Billion | $115.56 Million | 0.114x | +312.03% |
| 2021-12-31 | $1.41 Billion | $-75.43 Million | -0.054x | +16.36% |
| 2020-12-31 | $1.67 Billion | $-106.72 Million | -0.064x | -277.95% |
| 2019-12-31 | $1.29 Billion | $46.25 Million | 0.036x | -16.23% |
| 2018-12-31 | $1.58 Billion | $67.90 Million | 0.043x | -75.53% |
| 2017-12-31 | $1.59 Billion | $279.42 Million | 0.176x | +8.39% |
| 2016-12-31 | $1.66 Billion | $269.00 Million | 0.162x | +8.62% |
| 2015-12-31 | $1.42 Billion | $211.58 Million | 0.149x | +85.01% |
| 2014-12-31 | $1.28 Billion | $103.50 Million | 0.081x | +31.16% |
| 2013-12-31 | $1.32 Billion | $80.99 Million | 0.061x | -64.56% |
| 2012-12-31 | $1.28 Billion | $222.67 Million | 0.173x | -4.74% |
| 2011-12-31 | $1.48 Billion | $268.75 Million | 0.182x | +80.01% |
| 2010-12-31 | $1.38 Billion | $139.90 Million | 0.101x | -49.39% |
| 2009-12-31 | $700.40 Million | $139.92 Million | 0.200x | +287.81% |
| 2008-12-31 | $700.37 Million | $36.08 Million | 0.052x | 0.00% |
| 2007-12-31 | $700.37 Million | $36.08 Million | 0.052x | -40.57% |
| 2006-12-31 | $316.25 Million | $27.41 Million | 0.087x | -48.32% |
| 2005-12-31 | $98.42 Million | $16.51 Million | 0.168x | +6.04% |
| 2004-12-31 | $78.69 Million | $12.45 Million | 0.158x | +153.41% |
| 2003-12-31 | $83.39 Million | $5.21 Million | 0.062x | +149.74% |
| 2002-12-31 | $85.82 Million | $-10.77 Million | -0.125x | +62.45% |
| 2001-12-31 | $98.63 Million | $-32.96 Million | -0.334x | -289.26% |
| 2000-12-31 | $290.98 Million | $-24.98 Million | -0.086x | +54.44% |
| 1999-12-31 | $67.40 Million | $-12.70 Million | -0.188x | +74.43% |
| 1998-12-31 | $5.70 Million | $-4.20 Million | -0.737x | -- |
About Veradigm Inc.
Veradigm Inc., a healthcare technology company, provides information technology solutions to healthcare providers, payers, and biopharma markets in the United States and internationally. The company offers solutions to healthcare providers, comprising practice management software, AI patient scheduling software, and electronic statements and payments, and payerpath clearinghouse; revenue cycle se… Read more